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Impaired myocardial metabolism after cardioplegic arrest results in per- 
sistent anaerobic lactate production. Insulin may protect he heart from 
ischemia and reperfusion by enhancing myocardial metabolic recovery. 
However, the stimulation of glycolysis during ischemia may be detrimental 
because of an accumulation of metabolic end-products. We examined the 
effect of insulin on quiescent human ventricular cardiomyocytes subjected 
to simulated cardioplegic ischemia and reperfusion. Methods: Primary 
cardiomyocyte cultures were established from patients undergoing correc- 
tive repair of tetralogy of Fallot. Cells were xposed to varying concentra- 
tions of glucose and insulin during 30 minutes of stabilization i  10 mL of 
phosphate-buffered saline solution. Ischemia was simulated by exposing the 
cells to a low volume (1.5 mL) of deoxygenated phosphate-buffered saline 
solution for 90 minutes followed by 30 minutes of simulated reperfusion i  
10 mL of normoxic phosphate-buffered saline solution. Cell viability was 
assessed by trypan blue exclusion. The activity of mitochondrial pyruvate 
dehydrogenase was measured in 3 states: stabilization, ischemia, and 
reperfusion. In addition intracellular lactate, adenine nucleotides, extra- 
cellular lactate, pyruvate, and acid release were measured. Results: Higher 
ambient glucose concentrations resulted in greater cellular injury although 
insulin-treated cells displayed less injury after ischemia nd reperfusion. 
Insulin increased the pyruvate dehydrogenase activity by 31% in cardiomy- 
ocytes and reduced extracellular lactate production by 40%. Intracellular 
adenosine triphosphate was improved by 75% in cells exposed to high 
glucose concentrations in the presence of insulin. Conclusions: Insulin 
protected human ventrieular cardiomyocytes from ischeluia and reperfu- 
sion. This protection may be due to a stimulation of pyruvate dehydroge- 
nase activity which resulted in improved aerobic metabolism. (J Thorac 
Cardiovasc Surg 1998;116:485-94) 
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ardioplegic arrest and aortic crossclamping dur- 
ing surgery induces anaerobic myocardial metab- 
olism with a net production of lactate. In patients 
undergoing coronary bypass surgery, we observed 
persistent lactate release during reperfusion, sug- 
gesting a delayed recovery of normal aerobic metab- 
olismJ In a previous canine model of cardioplegic 
arrest and reperfusion, cardiac metabolism was eval- 
uated with lactate infusions labeled with radioactive 
carbon (14C).2 After cardioplegic arrest, there was 
14C-lactate xtraction by the heart despite a net 
myocardial lactate release. This suggests that exog- 
enous administration of lactate can alter myocardial 
substrate preference during cardioplegic arrest. 
However, the balance between lactate production 
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and lactate oxidation appears to favor anaerobic 
metabolism. In addition, the detection of myocar- 
dial lactate release grossly underestimates the true 
amount of anaerobic glycolysis because lactate pro- 
duced by ischemic regions of the heart may be 
extracted by normally functioning myocardium. The 
extent of anaerobic lactate production correlated 
with depressed postoperative l ft ventricular func- 
tion. Improving the transition from anaerobic lac- 
tate release to aerobic lactate oxidation during 
reperfusion may improve the tolerance to ischemia 
and enhance left ventricular function. 
In 1965, Sodi-Pollaris and colleagues 3 demon- 
strated a beneficial effect of an insulin solution on 
the electrocardiographic abnormalities in patients 
with acute myocardial infarction. Since that initial 
report, several investigators 4-6 have attempted to 
use glucose and insulin solutions to improve myo- 
cardial tolerance to ischemia. Unlike acute myocar- 
dial infarction, cardioplegic arrest during a cardiac 
operation provides a unique clinical situation in 
which myocardial ischemia can be anticipated and 
metabolic interventions introduced to improve cel- 
lular susceptibility to ischemia. An early study by 
Hearse and colleagues ~ demonstrated a detrimental 
effect of exogenous glucose infusions during isch- 
emic cardiac arrest. However, only a single car- 
dioplegic infusion was administered, and the dele- 
terious effects were attributed to an accumulation of
metabolic end-products uch as lactate and acid. 
Using a similar isolated, rat heart model, Doherty 
and colleagues 4 demonstrated a benefit of high 
doses of glucose and insulin by providing intermit- 
tent perfusion with hypothermic crystalloid cardio- 
plegia. This model effectively "washed out" the end 
products of glycolysis and prevented the cellular 
acidosis. The controversy regarding the effects of 
glycolytic stimulation during ischemia continues. 7' s 
We hypothesized that glycolytic stimulation during a 
"low flow" cardioplegic arrest condition may have a 
beneficial effect on cardiomyocyte survival. Specifi- 
cally, we believe that stimulation of mitochondrial 
pyruvate dehydrogenase (PDH) will allow an earlier 
recovery of aerobic metabolism after ischemia and 
improve cellular survival. 
Kobayashi and Neely 9 demonstrated that the ac- 
tivity of mitochondrial PDH was inhibited during 
the first 2 minutes of reperfusion after ischemia nd 
remained epressed for as long 45 minutes. Stimu- 
lation of PDit  after ischemia may lead to an im- 
proved transition from anaerobic to aerobic metab- 
olism. Weiss and Hiltbrand I° demonstrated that 
ATP produced from oxidative phosphorylation was 
preferentially used for contractile function. Thus, 
enhanced myocardial metabolic recovery after isch- 
emia may increase the ratio of aerobic to glycolytic 
ATP production and result in improved functional 
recovery. Insulin has been shown to stimulate mito- 
chondrial PDH in adipocytes and hepatocytes, llq3 
We hypothesized that insulin would stimulate PDH 
in cardiomyocytes before ischemia and prevent he 
inhibition of PDH activity after ischemia. 
This study used quiescent human ventricular car- 
diomyocytes to evaluate the effect of insulin on the 
cellular response to simulated ischemia and reper- 
fusion. The quiescent nature of these cardiomyo- 
cytes simulates cardioplegic arrest. In addition, the 
isolated cell culture model removes the possible 
confounding effects of other cell types and organ 
systems. The effects of circulating free fatty acids 14 
on myocardial substrate use are also absent in our 
model. Thus, this model permits an extensive met- 
abolic evaluation of isolated human cardiomyocytes 
subjected to simulated low-flow cardioplegic arrest 
and reperfusion. 
Methods 
Human ventricular cardiomyocyte culture. Cultures of 
human ventrieular cardiomyocytes were established as 
previously described. ~s' 16 in brief, 20 mg biopsies were 
obtained from the right ventricle of patients undergoing 
corrective repair of tetralogy of Fallot. The myocardial 
biopsies were washed in phosphate-buffered saline solu- 
tion without calcium (phosphate-buffered saline solution 
[PBS]: NaC1 136.9 mmol/L, KC1 2.7 mmol/L, Na2HPO 4 
8.1 mmol/L, KH2PO 4 1.5 mmol/L). After removing con- 
nective tissue, the myocytes were separated with enzy- 
matic digestion with a mixture of 0.2% trypsin (Difco 
Laboratories, Detroit, Mich.) and 0.1% collagenase 
(Worthington Biochemical Corp., Freehold, N.J.). The 
isolated cells were cultured at 37 ° C in 5% carbon dioxide 
and 95% air in lscove's modified Dulbecco's medium 
(GIBCO laboratories, Grand Island, N.Y.) containing 
10% fetal bovine serum, 100 U/mL penicillin, 100/,g/mL 
streptomycin, and 0.1 mmol/L/3-mercaptoethanol. Purifi- 
cation was achieved with the dilution cloning technique. 
Enzymatically isolated cells were seeded at a low density 
(50 to 100 cells per 9-cm diameter culture dish). At this 
low density, individual cardiomyocytes can be distin- 
guished morphologically b  their rectangular shape and 
large size (40 × 80/xm) from contaminating cells such as 
fibroblasts and endothelial cells. Culture purity greater 
than 95% was demonstrated in passage 3 with a fluores- 
cent monoclonal ntibody staining for human ventricular 
myosin heavy chain (Rougier Bio-Tech Ltd., Montreal, 
Quebec, Canada). Cells passaged 2 to 7 times with a time 
from primary culture of less than 60 days were used for 
this study. 
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Experimental protocols. The cardiomyocytes were 
studied in PBS with magnesium and calcium (MgC12 0.49 
mmol/L, CaC12 0.69 mmol/L). Our in vitro technique to 
simulate ischemia and reperfusion has been previously 
described in detailS" is Cells were stabilized for 30 min- 
utes in 10 mL of normoxic (Po 2 = 150 mm Hg) PBS with 
varying concentrations of insulin and glucose. Cardiople- 
gic ischemia was simulated by placing the cells into a 
sealed Plexiglas chamber flushed with 100% nitrogen and 
exposing the cells to a low volume (1.5 mL) of deoxygen- 
ated PBS. Deoxygenated PBS was prepared by degassing 
normoxic PBS with 95% nitrogen and 5% carbon dioxide 
until the measured Po 2 reached 0 mm Hg. Reperfusion 
was accomplished by exposure to 10 mL of normoxic PBS 
for 30 minutes. A small sample of deoxygenated PBS (2 
mL) was placed into a center dish in the chamber to 
monitor temperature and to confirm the absence of 
oxygen at the end of the ischemic period. The tempera- 
ture was maintained at 37 ° C throughout the experiment. 
The osmolality of the degassed PBS solutions was main- 
tained between 280 and 320 mOsm/L with sodium chlo- 
ride or water as required. 
Assessment  of  cellular injury. Cellular injury was as- 
sessed with non-confluent plates of cardiomyocytes (ap- 
proximately 337,000 cells per 9 cm diameter culture dish) 
cultured for 4 to 5 days after the last passage. After the 
intervention of interest, cell plates were incubated with 
0.4% trypan blue dye (Sigma Chemical Company, St. 
Louis, Mo.) dissolved in normal saline solution and as- 
sessed for injury under an inverted light microscope 
(Nikon Canada Instrument Inc., Mississauga, Ontario) at 
×200 magnification. Injured cells were unable to exclude 
the large molecular weight dye and stained blue. The 
number of blue-stained cells was counted from 5 standard 
locations on each plate and expressed as a percentage of 
the total number of cells. All counts were performed by a 
single observer who was blinded to the intervention. 
After a dose-response analysis for both glucose and 
insulin, we chose to compare 4 groups. A physiologic 
glucose concentration of 5 mmol/L was compared with a 
glucose concentration of 100 mmol/L. The latter concen- 
tration approximates the glucose concentration i  the 
cardioplegic solution currently used at our institution. The 
effects of 10 IU/L of insulin was then evaluated at both 
levels of glucose: group 1, 5 mmol/L glucose; group 2, 5 
mmol/L glucose and 10 IU/L insulin; group 3, 100 mmol/L 
glucose; group 4, 100 mmol/L glucose and 10 IU/L insulin. 
Biochemical measurements. The activity of PDH was 
measured after each inter-eention of interest with the 
modifications described by Robinson and colleagues 19of 
the method of Sheu and colleagues. 2°Cell extracts were 
aliquoted into separate Eppendorf tubes containing PBS. 
After incubation for 10 minutes, cells were treated with a 
buffer containing 25 mmol/L sodium fluoride and snap 
frozen in liquid nitrogen. Cell extracts were then reacted 
with a 14C-pyruvate containing buffer in an open Eppen- 
dorf insert and placed in sealed containers containing 
benzothonium hydroxide to trap ~4CO2. The reaction was 
stopped with 10% trichloroacetic acid, and 14CO2 col- 
lected for 1 hour. After the ~4CO2 collection, the cell 
inserts were removed and scintillation fluid was added to 
the exposed benzothonium hydroxide. The collected 
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Fig. 1. The effect of glucose and insulin on cellular injury 
after simulated ischemia nd reperfusion. (glucose ffect: 
F = 6.48, P < .0001, by 2-way ANOVA). The addition of 
10 IU/L of insulin at each glucose concentration reduced 
cellular injury (insulin effect: F = 24.26, P < .0001). 
Significant differences between insulin- and non-insulin- 
treated groups were specified at 50 and 100 mmol/L 
glucose. 
14CO2 was then counted in a/3-counter. PDH activity was 
calculated after correction for protein content and ex- 
pressed as nanomoles of pyruvate oxidized per milligram 
of protein per minute. 
Confluent cultures of cardiomyocytes (approximately 
600,000 cells per culture dish) cultured for 5 to 10 days 
from the last passage were used for biochemical analysis. 
After being removed from the culture dish, the cardiomy- 
ocytes and the extracellular fluid recovered from each 
intervention were analyzed for lactate by an enzymatic 
method (Stat-Pack rapid lactate test kit; Behring Diagnos- 
tics, La Jolla, Calif.). 
In a separate series of experiments, extracellular lactate 
and pyruvate were measured in the supernatant of each 
plate. Supernatants were collected and treated with a 
measured volume of 6% perchloric acid to inhibit enzy- 
matic degradation. Lactate concentrations were deter- 
mined as described earlier. Pyruvate concentrations were 
determined using a lactate dehydrogenase coupled reac- 
tion. 19 The concentration of hydrogen ion in the extracel- 
lular fluid was determined by measuring the pH value with 
a blood gas analyzer (1312 Blood Gas Manager; Instru- 
mentation Laboratory, Milano, Italy). 
Confluent plates of cardiomyocytes were used to deter- 
mine cellular adenine nucleotide contents after the inter- 
vention of interest. The specimens were flash frozen in 
liquid nitrogen and then freeze-dried. Specimens were 
analyzed by high-performance liquid chromatography to 
determine the myocardial concentrations of adenosine 
triphosphate (ATP), adenosine diphosphate (ADP) and 
adenosine monophosphate (AMP). We also measured the 
metabolites adenosine, inosine, hypoxanthine and xan- 
thine. Total adenine nucleotides were determined as the 
sum of ATP, ADP and AMP. Total degradation products 
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Fig. 2. PDH activity after 30 minutes of exposure to glucose and insulin (stabilization), 90 minutes of 
ischemia, and 30 minutes of reperfusion, insulin exposure increased PDH activity at both levels of glucose 
before ischemia nd prevented PDH inactivation aftcr reperfusion. Results are expressed as a percentage 
of control values obtained at baseline or from cells exposed to equivalent volumes of normoxic PBS for 
equivalent time periods. 
were calculated as the sum of adenosine, inosine, hypo- 
xanthine, and xanthine. Energy charge represents the 
usable high-energy phosphate pool and was calculated as: 
cnergy charge = (ATP + 0.5 ADP)/(ATP + ADP + 
AMP). The DNA in the cell extracts was recovered in 5% 
perchloric acid and quantitatcd with a spectrophotomet- 
ric, diphenylamine color reaction with calf thymus DNA 
as the standard. 1 Intracellular and extracellular lactate 
and adenine nucleotide values were then corrected for 
DNA content from each plate.~8 
Non-ischemic control cardiomyocytcs were subjected to 
similar protocols with equivalent volumes of normoxic 
PBS (Po 2 - 150 mm Hg) for equal time periods as their 
ischemic counterparts. Baseline biochemical measure- 
ments were made alter removing the culture media and 
washing the cells with normoxic PBS. In a separate series 
of experiments designed to eliminate the effects of glu- 
cose, cells were exposed to 5 or 100 mmol/L of mannitol 
with or without insulin. 
Statistical analysis. The SAS Statistical Package (SAS 
Institute, Cary, N.C.) was used for analysis of all data. 
Data are expressed as the mean ± standard error with 8 
plates per group, unless otherwise specilied. Biochemical 
end points are expressed as a percentage of the value 
obtained from non-ischemic control plates exposed to an 
equivalent volume of normoxic PBS for the equivalent 
period of time. Analysis of variance (ANOVA) was used 
to simultaneously compare groups at diffcrcnt ime peri- 
ods. When statistically significant differences were found, 
they were specified by the Duncan's multiple range test. 
Resu l ts  
Assessment  o f  cellular injury. An insulin dose 
response curve was performed with a glucose con- 
centration of 5 mmol/L (physiologic) and 100 
mmol/L (experimental). Increasing the insulin con- 
centration from 0 to 100 IU/L did not reduce 
cellular injury at a glucose concentration of 5 
mmol/L (0, 39% ± 3%; 10, 35% +_ 2%; 50, 35% _+ 
3%; 100, 37% _+ 2%; F = 0.27, P = .84 by 
ANOVA) .  However, when cells were exposed to a 
glucose concentration of 100 retool/L, the addition 
of insulin reduced cellular injury (no insulin 48% ± 
3% vs 10 IU/L insulin 37% ± 2%; F = 4.48, P = .01 
by ANOVA) .  No further protection could be dem- 
onstrated by increasing the insulin concentration 
from 10 IU/L  to 100 IU/L (50, 38% _+ 1%; 100, 39% 
_+ 2%; P > .05 compared with 10 IU/L  insulin by 
Duncan's multiple range test). 
A glucose dose-response curve (Fig. 1) demon- 
strated higher cell injm3~ with increasing glucose 
concentration (by 2-way ANOVA,  glucose effect 
F = 6.48, P < .0001). The addition of 10 IU/L of 
insulin at each glucose concentration reduced cellu- 
lar injuq¢ (insulin effect F = 24.26, P < .0001). 
There was no interactive effect between glucose 
concentration and insulin treatment (glucose-insulin 
effect F = 2.05, P = .08). Significant differences 
between insulin- and non-insulin-treated groups 
were found at 50 and 100 mmol/L glucose. 
Effect on PDH activity. Fig. 2 demonstrates PDH 
activity after stabilization, ischemia, and reperfll- 
sion. Insulin exposure increased PDH activity at 
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both levels of glucose. Cells exposed to 100 mmol/L 
glucose also increased PDH activity compared with 
5 mmol/L glucose with or without insulin. PDH 
activity was inhibited after ischemia in the groups 
with 5 mmol/L of glucose, although those cells 
exposed to 100 mmol/L of glucose with or without 
insulin retained PDH activities near control levels. 
After reperfusion, only those cells exposed to 100 
mmol/L of glucose and insulin retained normal PDH 
activities; all other groups had inhibited activity. 
To eliminate a glucose effect, cells were subjected 
to 5 or 100 mmol/L of mannitol with or without 10 
IU/L of insulin. Fig. 3 illustrates the ability of insulin 
to stimulate PDH independent of glucose. 
Effect on intermediary metabolites. Fig. 4 (top 
panel) displays the intracellular lactate accumula- 
tion that was highest in cells exposed to 100 mmol/L 
of glucose and insulin during stabilization and reper- 
fusion. However, after 90 minutes of ischemia, 
intracellular lactate accumulation i cells exposed to 
100 mmol/L of glucose was lower when insulin was 
added. Ischemia and reperfusion increased intracel- 
lular lactate in all groups. 
Fig. 4 (middle panel) illustrates extracellular lac- 
tate release measured in the supernatant over each 
plate. Ischemia resulted in a large increase in lactate 
release in all groups. Extracellular lactate release 
remained elevated after reperfusion in all groups, 
suggesting persistent anaerobic metabolism. Lactate 
release was lower in the insulin-treated cells. 
Fig. 4 (bottom panel) displays total cellular lactate. 
Insulin treatment lowered total cellular lactate dur- 
ing stabilization, ischemia, and reperfusion. Simi- 
larly, extracellular pyruvate concentrations were 
lower in the insulin-treated cells. The lactate/pyru- 
vate ratios were higher in the cells exposed to high 
concentrations of glucose. Table I displays the lac- 
tate, pyruvate, PDH, and pH measurements after 
each intervention. 
Adenine nueleotides. The intracellular levels of 
adenine nucleotides and their metabolites are given 
in Table II. Fig. 5 illustrates the fall in ATP in all 
groups after ischemia. Intracellular ATP was best 
preserved in the group with 100 mmol/L glucose and 
insulin compared with the groups with 5 mmol/L 
glucose. Reperfusion resulted in only a small in- 
crease in intracellular ATP, with all 4 groups re- 
maining well below non-ischemic ontrol values. 
Similarly, ischemia resulted in a significant fall in 
total adenine nucleotides in all groups; however, 
they were best preserved in the group with 100 
mmol/L glucose and insulin. After reperfusion, total 
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Fig. 3. PDH activity after 30 minutes of exposure to 
mannitol (5 or 100 mmol/L) and insulin (0 or 10 IU/L). 
Insulin resulted in similar PDH stimulation at both levels 
of mannitol, indicating that the stimulatory effect is inde- 
pendent of a glucose transport effect. 
adenine nucleotides were higher in the high-glucose 
groups but remained below 50% of control values. 
Discussion 
During ischemia, fatty acid oxidation is inhibited, 
and glycolytic ATP production predominates. In a 
clinical study examining patients who were under- 
going coronary bypass operation, we found that 
14C-labeled fatty acid oxidation was inhibited for as 
long as 60 minutes after cardioplegic arrest. 22 In 
addition, during reperfusion there is a delay in the 
recovery of normal aerobic glucose metabolism. 
Several clinical trials at our institution demonstrate 
persistent lactate release during reperfusion, which 
suggests continued anaerobic glycolysis] '23'24 Be- 
cause net myocardial lactate release is an underes- 
timate of total lactate production, due to a low level 
of continuous myocardial lactate extraction, we be- 
lieve that cardioplegic arrest results in a significant 
impairment of normal aerobic metabolism. Improv- 
ing the transition from anaerobic to aerobic metab- 
olism after cardioplegic arrest should improve tol- 
erance to ischemia and enhance the recovery of 
ventricular function. 
Several investigators have attempted to stimulate 
glucose oxidation during reperfusion to improve 
myocardial functional recovery. 2s-;7 These authors 
used dichloroacetate to stimulate PDtt  activity that 
resulted in an improvement in glucose oxidation and 
myocardial functional recovery after ischemia. How- 
ever, Mazer and colleagues a~ found that dichloroac- 
490 Rao et al. 
The Journal of Thoracic and 
Cardiovascular Surgery 
September 1998 
600% 
.~ 500% 
400% 
"~ 300% 
o 200% 
10o% 
0% 
800% 
"¢~ 600% 
L 
"~ 400% 
¢.~ 
200./0 
0% 
800% 
600%, 
400% 
200% 
p<0.05 vs No Insul in "[ [] no ~sta~ cl e*strt~ ]
"p<0.05 vs No Insulin 
*p<0.05 vs No Insulin 
0% 
Glucose 5 100 5 100 5 100 
mmol/L STABIL IZAT ION ISCHEMIA  REPERFUSION 
Fig. 4. Top panel, Intracellular lactate accumulation after 30 minutes of stabilization, 90 minutes of 
ischemia, and 30 minutes of reperfusion. Lactate xtraction during stabilization and reperfusion was higher 
in group 4. However, lactate accumulation was lower in group 4 after ischemia. Middle panel, Extracelhflar 
lactate release into the supernatant over each plate. Lactate release increased significantly with ischemia 
and remained elevated uring reperfusion, suggesting persistent anaerobic metabolism. Insulin treatment 
reduced lactate release at both glucose concentrations. Bottom panel, Total cellular lactate increases 
during ischemia nd remains elevated uring reperfusion. Insulin treatment reduced total cellular lactate 
during stabilization, ischemia, and reperfusion. Results are expressed as a percentage of control values 
obtained at baseline or from cells exposed to equivalent volumes of normoxic PBS for equivalent time 
periods. 
etate did not improve systolic function in the in vivo 
porcine heart, despite an increase in glucose oxida- 
tion. Therefore alternative methods of PDH stimu.- 
lation may prove to be superior to dichloroacetate in 
enhancing myocardial functional recovery after isch- 
emia. 
Insulin has been shown to stimulate PDtt  activity 
in adipocytes, 12 hepatocytes, 11 and cardiomyo- 
cytesJ 3 The mechanism by which insulin stimulates 
PDH remains controversial. The PDH complex is 
regulated by a PDH phosphatase and a PDH kinase. 
Phosphorylation of the complex by PDH kinase 
renders it inactive, although dephosphorylation by
the phosphatase returns the complex to its active 
form. Lilley and colleagues a3 found that insulin in 
bovine heart mitochondria preferentially stimulates 
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Table I. Extracellular lactate and pyruvate production 
Time period (rain) 
5 5 + I 100 100 + I Control 
Stabilization 
Lactate (mol/min/g) 1.6 (0.3) 1.2 (0.1)* 1.8 (0.2) 1.2 (0.2)* 1.5 (0.6) 
Pyruvate (mol/min/g) 33 (5) 21 (3)* 30 (6) 19 (2)'i"$ 36 (5) 
Lactate/pyruvate ratio 52 (8) 60 (9) 63 (6) 65 (9)t 47 (5) 
Extracellular pH 7.27 (0.04) 7.21 (0.03)* 7.19 (0.05) 7.21 (0.04) 7.25 (0.05) 
PDH activity (nmol/mg) 0.76 (0.04)t 0.88 (0.09)*'~ 0.96 (0.13)$ 1.26 (0.12)*->~: 0.96 (0.09) 
Ischemia 
Lactate (mol/min/g) 3.0 (0.6)# 2.7 (0.5)t 4.6 (0.5)?$ 2.9 (0.6)*~ 1.1 (0.3) 
Pyruvate (mol/min/g) 73 (11) 43 (8)*-> 72 (10) 46 (8)*'I'$ 76 (10) 
Lactate/pyruvate ratio 40 (3)t 64 (3)*'~ 65 (3)-> 62 (20)i 20 (4) 
Extracellular pH 7.10 (0.03)> 7.10 (0.04)1 7.03 (0.03)'> 7.08 (0.04)'> 7.24 (0.03) 
PDH activity (nmol/mg) 0.62 (.04) 0.68 (0.04)t 0.91 (0.09); 0.96 (0.10),+. 1.03 (0.08) 
Reperfusion 
Lactate (mol/min/g) 1.3 (0.4)'> 1.0 (0.1)'> 2.0 (0.3)t$ 1.2 (0.2)*-> 0.4 (0.1) 
Pyruvate (mol/min/g) 41 (6)t 27 (5)*-> 42 (6)'> 27 (6)*t$ 61 (5) 
Lactate/pyrttvate ratio 32 (5)'~ 40 (3)'~ 48 (4)'> 47 (6)'~ 9 (1) 
Extracellular pH 7.24 (0.04) 7.26 (0.03) 7.22 (0.04) 7.26 (0.03) 7.27 (0.03) 
PDH activity (nmol/mg) 1.01 (0.11)'> 1.20 (0.10)*t 1.22 (0.09)'> 1.51 (0.08)*$ 1.64 (0.09) 
All data are mean (SEM). Control plates assessed at baseline (stabilization) or after 120 minutes (ischemia) or 150 minutes (reperfusion) of incubation in 
normoxic phosphate-buffered saline solution. 
*P < .05 vs no insulin. 
"t'P < .05 vs control. 
:~P < .05 vs 5. 
the PDH phosphatase. In contrast, dichloroacetate 
causes PDH stimulation by inhibiting the PDH 
kinase. 
The ability of pre-ischemic insulin exposure to 
stimulate post-ischemic PDH activity in human 
myocardial tissue has not previously been demon- 
strated. This study examined the clinically relevant 
effects of pre-ischemic exposure to insulin in the 
presence of physiologic or hyperglycemic concentra- 
tions of glucose. Insulin was found to stimulate PDH 
activity before ischemia nd partially prevented the 
inhibition of PDH activity during reperfusion. In 
addition, insulin treatment reduced extracellular 
lactate release and improved the preservation of 
ATP. The beneficial metabolic effects of insulin 
were found to protect against cellular injury after 
simulated ischemia nd reperfusion. 
Cell culture model. The cardiomyocytes u ed in 
these studies have been extensively evaluated in 
previous reports. 15-1s These cardiomyocytes retain 
many characteristics of freshly isolated cells but 
have distinct differences. These cells become quies- 
cent after enzymatic digestion and passaging. Other 
investigators 29who have successfully cultured adult 
cardiomyocytes have reported that the cells lose 
their ability to contract. Despite an abundant supply 
of mitochondria and contractile proteins, the sarco- 
meres become disrupted uring division and do not 
reestablish their characteristic functional format. 
ttowever, the metabolic response of these cells after 
ischemia is similar to our intraoperative findings 
during cardiac operations, l' 9_2-24 Therefore we be- 
lieve that these cells provide a unique opportunity to 
evaluate the cellular response to ischemia and 
reperfusion and the effects of metabolic interven- 
tions such as insulin. 
Simulated ischemia and reperfusion. We are 
able to produce a deoxygenated PBS solution with a 
measured Po 2 of 0 mm Hg. iv Exposing cells to 90 
minutes of ischemia resulted in significant cellular 
injury as assessed by trypan blue exclusion. Reduc- 
ing the volume of the solution over the cells from 10 
mL to 1.5 mL and exposure to an anoxic atmosphere 
resulted in an accumulation of the products of 
ischemic metabolism and a marked reduction in the 
extracellular pH. Therefore this model is similar to 
the effects of global ischemia on the heart. Unfor- 
tunately, the volume overlying the cells remains 
greater than the solution to which the cells arc 
exposed during global ischemia and may actually 
represent a form of low-flow ischemia, analagous to 
limited cardioplegic perfusion. 
We believe that our model represents low-flow 
ischemia rather than hypoxia because of the volume 
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Table II. Intracellular adenine nucleotide concentrations 
Time period (rain) 
Nucleotide 5 5 + I 100 100 + I Control 
Stabilization 
ATP 1.9 (1.0) 2.7 (1.0)* 3.1 (1.5)*? 2.5 (0.9) 2.0 (1.0) 
ADP 0.8 (0.2)* 1.0 (0.4) 0.9 (0.2)* 1.3 (0.3) 1.6 (0.3) 
AMP 0,1 (0.1)* 0.3 (0.2)* 0.7 (0.4) 0.9 (0.3) 1.1 (0.2) 
Inosine 0.4 (0.2)* 0.4 (0.2)* 0.6 (0.2)* 0.9 (0.3) 1.1 (0.2) 
Adenosine 0.3 (0.2)* 0.4 (0.2)* 1.0 (0.3) 1.4 (0.5) 1.1 (0.3) 
Energy charge 0.81 (0.08) 0.80 (0.12) 0.77 (0.15) 0.75 (0.13) 0.71 (0.10) 
Ischemia 
ATP 0.3 (0.1))* 0.3 (0.1)* 0.2 (0.1)* 0.5 (0.2)** 1.8 (0.2) 
ADP 0.2 (0.t)* 0.3 (0.1)* 0.2 (0.2)* 0.3 (0.1)* 0.8 (0.1) 
AMP 0.1 (0.1)* 0.1 (0.1)* 0.1 (0.1)* 0.l (0.1)* 0.8 (0.1) 
Inosine 0.8 (0.2) 0.9 (0.4) 0.9 (0.6) 1.3 (0.3)* 0.5 (0.2) 
Adenosine 0.2 (0.1) 0.4 (0.2) 0.4 (0.2) 0.6 (0.2) 0.3 (0.2) 
Energy charge 0.72 (0.04) 0.64 (0.07) 0.71 (0.08) 0.70 (0.09) 0.65 (0.02) 
Reperfusion 
ATP 0.4 (0.1)* 0.4 (0.1)* 0.6 (0.2)* 0.7 (0.2)*? 1.9 (0.4) 
ADP 0.2 (0.1)* 0.2 (0.1)* 0.4 (0.1)* 0.4 (0.t)* 0.9 (0.2) 
AMP 0,2 (0.1)* 0.2 (0.1)* 0.6 (0.2)? 0.3 (0.2) 0.5 (0.2) 
Inosine 0.3 (0.1)* 0.5 (0.2) 0.7 (0.3)? 0.6 (0.1) 0.6 (0.3) 
Adenosine 0.2 (0.1)* 0.2 (0.1) 0.3 (0.1) 0.3 (0.1) 0.4 (0.1) 
Energy charge 0.61 (0.03)* 0.61 (0.06)* 0.57 (0.10)* 0.66 (0.07)$ 0.71 (0.07) 
All values are reported as millimoles per gram DNA; mean (STD). Control plates assessed at baseline (stabilization) or after 120 minutes (ischemia) or 150 
minutes (reperfusion) of incubation in normoxic phosphate-buffered saline solution. 
*P < .05 vs control. 
"~P < .05 vs 5 mmol/L glucose. 
:)P < .05 vs no insulin. 
differences. When the cells are exposed to 90 min- 
utes of hypoxia with 10 mL of deoxygenated PBS, 
the biochemical abnormalities are much less severe 
and cellular injury is only 25% to 30%, compared 
with approximately 45% with 1.5 mL of anoxic 
PBS. 3° Therefore the volume changes over the 
culture dishes result in a greater ischemic insult than 
occurs with simple hypoxia and reoxygenation. 
There was an increase in PDH activity after an 
increase in PBS volume to t0 mL in the control 
plates. This increase in PDH activity in the control 
plates was due to a decrease in the extracellular 
lactate concentration and a sharp fall in the lactate/ 
pyruvate ratio causing inhibition of the PDtt  !dnase. 
Similarly, stabilization in PBS with 5 mmol/L of 
glucose resulted in an inhibition of PDH activity, 
compared with cells recovered irectly from culture 
media. This inhibition was associated by a rise in the 
lactate/pyruvate ratio. However, PDH activity was 
higher in cells exposed to high glucose or insulin. 
Insulin's effect on PDH activity. We found that 
insulin treatment resulted in a stimulation of PDH 
activity. Similar findings have been reported by 
several authors in various organ systems. 11-13 Koba- 
yashi and Neely 9 found that PDH activity was 
inhibited after ischemia within 2 minutes of reper- 
fusion. We found that PDH activity was inhibited at 
the end of ischemia. Our technique of measuring 
PDH involves approximately 10 minutes of incuba- 
tion in PBS. Thus, our measurement of PDH activity 
after ischemia may correlate with 10 minutes of 
reperfusion in Kobayashi and Neely's model. In 
addition, Kobayashi and Neely demonstrated a 55% 
inhibition of PDH activity during reperfusion. The 
magnitude of PDH inhibition in our model was 
much less severe (20% to 45% at end of ischemia). 
Cells treated with high glucose displayed better 
preservation of PDH activity after ischemia. High 
extracellular glucose concentrations may increase 
intracellular diacylglycerol levels with a resultant 
stimulation of protein kinase C. Benelli and col- 
leagues ~:1 found that protein kinase C mediated 
insulin's ability to stimulate PDH activity in cultured 
hepatocytes. After 30 minutes of reperfusion, PDH 
activities were still depressed compared with con- 
trol, non-ischemic values; however, the high-glu- 
cose- and insulin-exposed cells displayed a better 
recovery of PDH activity. Because our experimental 
protocol involved only a 30-minute exposure to 
insulin, we do not feel that insulin's stimulatory 
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Fig. 5. Intracellular ATP levels after stabilization, after 90 minutes of ischemia, and after 30 minutes of 
reperfusion. ATP fell significantly in all groups but was better preserved in group 4 (100 mmol/L glucose 
and 10 IU/L insulin). Results are expressed as a percentage ofcontrol values obtained at baseline or from 
cells exposed to equivalent volumes of normoxic PBS for equivalent time periods. 
effect involves an increase in protein synthesis. 
Rather, insulin exposure results in an increased 
activity of native PDH. 
Insulin's effect on intermediate metabolites. In- 
sulin-treated cells produced less lactate and pyru- 
vate than non-insulin-treated cells. After ischemia, 
intracellular lactate accumulation was significantly 
higher in the 100 mmol/L glucose group. Insulin 
reduced intracellular lactate to levels similar to that 
in groups with 5 mmol/L of glucose. However, 
lactate extraction was higher after reperfusion in 
cells exposed to 100 mmol/L glucose and insulin. 
Both intracellular and extracellular lactate concen- 
trations were significantly higher in all groups during 
reperfusion, compared with the non-ischemic on- 
trols. This persistent anaerobic glycolysis has been 
observed in patients who are undergoing cardiac 
operation.l' 22-24 
Insulin's effect on adenine nucleotides. Insulin 
treatment resulted in a better preservation of intra- 
cellular ATP and total adenine nucleotides after 
ischemia and reperfusion. This may be due to the 
higher activity of PDH during reperfusion. Higher 
PDH activity improves the etficiency of ATP pro- 
duction by stimulating oxidative metabolism. How- 
ever, both ATP and total adenine nucleotide levels 
remained well below control values. The improve- 
ment in high-energy phosphates may simply be due 
to higher preischemic values. However, preischemic 
ATP levels were higher in the 100 mmol/L glucose 
group than in the 100 mmol/L glucose and insulin 
group, yet ATP levels were better preserved in the 
latter group. 
The ratio of oxidatively derived ATP to ATP 
derived from glycolysis may be higher in the insulin- 
treated group. We did not directly measure oxida- 
tive phosphorylation i these studies. Weiss and 
Hiltbrand 1° described a functional compartmenta- 
tion of energy production in isolated rabbit hearts. 
They reported that aerobically derived ATP was 
preferentially used for contractile function whereas 
ATP derived from anaerobic glycolysis was used 
preferentially to support sarcolemmal function. We 
are unable to measure contractile function in this 
model. Demonstration of an improved transition 
from anaerobic to aerobic metabolism with an eval- 
uation of the effect on contractile function will 
require further investigation. 
Significance. We have demonstrated that pre- 
ischemic exposure to insulin improves cellular tol- 
erance to simulated ischemia and reperfusion in 
isolated human ventricular cardiomyocytes. We be- 
lieve that this is the first report to demonstrate hat 
in isolated human myocardial tissue: 
1. The activity of PDH is inhibited by 40% after 
ischemia and remained epressed after 30 minutes 
of reperfusion. 
2. Insulin stimulated PDH activity by 31% before 
ischemia and partially prevented the inhibition of 
PDH activity after reperfusion. 
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3. Insulin treatment reduced extracellular lactate 
release by 37% after ischemia and by 40% after 
reperfusion. Intracellular high-energy phosphate 
levels were improved by 75% in cells exposed to 
high glucose and insulin, and total pool size of 
purine nucleotides was increased. 
The results of these investigations uggest that 
insulin treatment can enhance human myocardial 
PDH activity, improve the transition from anaerobic 
to aerobic metabolism, and result in improved cel- 
lular survival after ischemia and reperfusion. These 
findings may prove important in clinical situations of 
controlled ischemia, such as cardioplegic arrest dur- 
ing cardiac operations. Although we have per- 
formed an extensive evaluation of the metabolic 
response to ischemia, the results require confirma- 
tion in a whole organ model. 
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